Who
Yifan Zhai
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Ascentage Pharma Group International.
In numbers
- Trades disclosed
- 24
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 20 May 2026
- Last trade
- 21 May 2026
- Last filed
- 22 May 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 May 2026filed 22 May 2026 | AAPG Ascentage Pharma Group InternationalBiotechnology | SEC FORM 4 Code M | —92,746 at $0.00 | filing |
| 21 May 2026filed 22 May 2026 | AAPG Ascentage Pharma Group Internationaloption or derivative · Biotechnology | SEC FORM 4 Code M | —95,575 at $0.00 | filing |
| 21 May 2026filed 22 May 2026 | AAPG Ascentage Pharma Group InternationalBiotechnology | SEC FORM 4 Code M | —95,575 at $0.00 | filing |
| 21 May 2026filed 22 May 2026 | AAPG Ascentage Pharma Group Internationaloption or derivative · Biotechnology | SEC FORM 4 Code M | —92,746 at $0.00 | filing |
| 21 May 2026filed 22 May 2026 | AAPG Ascentage Pharma Group Internationaloption or derivative · Biotechnology | SEC FORM 4 Code M | —95,575 at $0.00 | filing |
| 21 May 2026filed 22 May 2026 | AAPG Ascentage Pharma Group Internationaloption or derivative · Biotechnology | SEC FORM 4 Code M | —92,746 at $0.00 | filing |
| 21 May 2026filed 22 May 2026 | AAPG Ascentage Pharma Group InternationalBiotechnology | SEC FORM 4 Code M | —92,746 at $0.00 | filing |
| 21 May 2026filed 22 May 2026 | AAPG Ascentage Pharma Group InternationalBiotechnology | SEC FORM 4 Code M | —95,575 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | AAPG Ascentage Pharma Group Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —298,195 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | AAPG Ascentage Pharma Group Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —298,194 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | AAPG Ascentage Pharma Group Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —103,365 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | AAPG Ascentage Pharma Group Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —103,365 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | AAPG Ascentage Pharma Group Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —214,999 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | AAPG Ascentage Pharma Group Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —214,988 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | AAPG Ascentage Pharma Group Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —103,364 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | AAPG Ascentage Pharma Group Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —92,746 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | AAPG Ascentage Pharma Group Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —95,575 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | AAPG Ascentage Pharma Group Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —298,195 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | AAPG Ascentage Pharma Group Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —298,194 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | AAPG Ascentage Pharma Group Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —214,999 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.